Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
457 Engineered tumor-infiltrating lymphocytes (TIL) with ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
457 Engineered tumor-infiltrating lymphocytes (TIL) with co-regulated membrane-bound IL15 (mbIL15) and LIGHT (TNFSF14) generate significant antitumor efficacy in fibrotic tumor models
0
Authors
Benjamin Primack
15 more
Benjamin Primack
•
Balázs Koscsó
13 more
•
Jeremy Tchaicha
Published
November 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Regular and Young Investigator Award Abstracts
Topics
Chemistry
Cancer Oncology
Medicine
Immunology
Biotechnology
Show all topics
DOI
10.1136/jitc-2024-sitc2024.0457
